SRR and endothelial dysfunction: More clinical trials are warranted to translate promising approaches from animal studies to human clinical trials, e.g., serine racemase inhibition, or to investigate agents that have been studied with regard to endothelial dysfunction but not in the context of stroke, e.g., SSRIs.